X
Get new exclusive access to healthcare business reports & breaking news
Biotech
Pharmaceutical compounding has existed for a long time. However, it has gained traction in recent years as more ...
The world of cancer research provides some great news as Genentech strikes a deal with Vaccibody to partner ...
Komodo Health announced recently that it would be acquiring Mavens, in line with its mission to expand its ...
Positive results proving an overall survival (OS) benefit from the Phase 3 trial investigating Sanofi and Regeneron’s PD-1 ...
The Food and Drug Administration (FDA) recently released draft guidance to producers of human gene therapy products for ...
Recently, Amgen (NASDAQ: AMGN) announced that the FDA (Food and Drug Administration) has granted the company’s investigational KRASG12C ...
A Swedish pharmaceutical company that has developed a broad portfolio of drug candidates, announced earlier this month (December ...
Sanofi, a leading global vaccine manufacturer, has experienced a major setback in its goal of quickly producing a ...
![[Podcast] Are Stem Cells the Answer to COVID-19 long term damage to the human body?](https://healthcareweekly.com/wp-content/uploads/2020/07/shutterstock_1773310655.jpg)
Today’s guest is Dr. Anand Srivastava. He is the Co-founder, Chairman and Chief Scientific Officer of GIOSTAR. GIOSTAR ...
